The store will not work correctly when cookies are disabled.
amino(2-(4-cyanobenzylidene)hydrazinyl)methaniminium chloride
ID: ALA2346957
PubChem CID: 71720800
Max Phase: Preclinical
Molecular Formula: C9H10ClN5
Molecular Weight: 187.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: Amino(2-(4-Cyanobenzylidene)Hydrazinyl)Methaniminium Chloride | CHEMBL2346957|Amino(2-(4-Cyanobenzylidene)Hydrazinyl)Methaniminium Chloride|BDBM50490865
Canonical SMILES: Cl.N#Cc1ccc(/C=N/NC(=N)N)cc1
Standard InChI: InChI=1S/C9H9N5.ClH/c10-5-7-1-3-8(4-2-7)6-13-14-9(11)12;/h1-4,6H,(H4,11,12,14);1H/b13-6+;
Standard InChI Key: KSPMYRYFPLBEKN-AWFSDRIXSA-N
Molfile:
RDKit 2D
15 14 0 0 0 0 0 0 0 0999 V2000
8.7291 -17.3261 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.6730 -16.4016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6719 -17.2211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3799 -17.6301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0896 -17.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0868 -16.3980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3781 -15.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7979 -17.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5050 -17.2184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2134 -17.6259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9204 -17.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6288 -17.6237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9191 -16.3990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9618 -15.9914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2540 -15.5829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
5 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
14 15 3 0
2 14 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 187.21 | Molecular Weight (Monoisotopic): 187.0858 | AlogP: 0.38 | #Rotatable Bonds: 2 |
Polar Surface Area: 98.05 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.42 | CX LogP: 0.82 | CX LogD: -0.22 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.35 | Np Likeness Score: -1.85 |
References
1. Ring JR, Zheng F, Haubner AJ, Littleton JM, Crooks PA.. (2013) Improving the inhibitory activity of arylidenaminoguanidine compounds at the N-methyl-D-aspartate receptor complex from a recursive computational-experimental structure-activity relationship study., 21 (7): [PMID:23465801] [10.1016/j.bmc.2013.01.051] |
2. Kim SH, Semenya D, Castagnolo D.. (2021) Antimicrobial drugs bearing guanidine moieties: A review., 216 [PMID:33640673] [10.1016/j.ejmech.2021.113293] |